Zimmerman R S, Trippodo N C, MacPhee A A, Martinez A J, Barbee R W
Division of Research, Alton Ochsner Medical Foundation, New Orleans, La.
Circ Res. 1990 Aug;67(2):461-8. doi: 10.1161/01.res.67.2.461.
Atrial natriuretic factor (ANF) causes plasma fluid to shift out of the circulation and enhances the escape of radiolabeled albumin. Examination of the mechanisms by which ANF alters microcirculatory fluid and protein transfer will likely require studies in localized vascular regions. This study was aimed at determining the specific organs in which ANF increases the escape of albumin. Anesthetized, splenectomized rats that had both kidneys removed were infused with vehicle alone or rat ANF-(99-126) at 0.025, 0.05, 0.1, or 0.5 micrograms.min-1.kg-1 for 2 hours (n = 8 per group). Total red cell and plasma volumes were measured with chromium-51-labeled erythrocytes and iodine-125-labeled albumin, respectively. At the end of 2 hours, the rats were frozen in liquid nitrogen, and organ blood volumes and tissue 125I-albumin were determined. ANF decreased plasma volume at infusion rates of 0.1 and 0.5 micrograms.min-1.kg-1. ANF increased the rate at which 125I-albumin escaped from the overall circulation at infusion rates of 0.1 and 0.5 micrograms.min-1.kg-1. At an ANF infusion rate of 0.1 micrograms.min-1.kg-1, the albumin escape rate increased in the gastrointestinal tract, skeletal muscle, heart, and lungs. At an infusion rate of 0.5 micrograms.min-1.kg-1, the albumin escape rate increased in the gastrointestinal tract, muscle, and skin, but not the lungs. These findings suggest that at pathophysiological levels, ANF shifts protein out of the circulation in peripheral vascular beds and the lungs and may contribute to pulmonary edema in states such as congestive heart failure. At pharmacological levels, ANF may be protective of the lungs by preventing increased pulmonary albumin escape.
心房利钠因子(ANF)可使血浆液体从循环中移出,并增强放射性标记白蛋白的逸出。研究ANF改变微循环液体和蛋白质转运的机制可能需要在局部血管区域进行研究。本研究旨在确定ANF增加白蛋白逸出的特定器官。对麻醉后切除脾脏且双侧肾脏摘除的大鼠,分别以0.025、0.05、0.1或0.5微克·分钟⁻¹·千克⁻¹的速率输注溶剂或大鼠ANF-(99 - 126),持续2小时(每组n = 8)。分别用铬⁵¹标记的红细胞和碘¹²⁵标记的白蛋白测量总红细胞和血浆容量。2小时结束时,将大鼠置于液氮中冷冻,测定器官血容量和组织碘¹²⁵白蛋白含量。在输注速率为0.1和0.5微克·分钟⁻¹·千克⁻¹时,ANF可降低血浆容量。在输注速率为0.1和0.5微克·分钟⁻¹·千克⁻¹时,ANF可增加碘¹²⁵白蛋白从整体循环中的逸出速率。在ANF输注速率为0.1微克·分钟⁻¹·千克⁻¹时,胃肠道、骨骼肌、心脏和肺中的白蛋白逸出速率增加。在输注速率为0.5微克·分钟⁻¹·千克⁻¹时,胃肠道、肌肉和皮肤中的白蛋白逸出速率增加,但肺中未增加。这些发现表明,在病理生理水平,ANF可使外周血管床和肺中的蛋白质从循环中移出,可能在诸如充血性心力衰竭等状态下导致肺水肿。在药理水平,ANF可能通过防止肺白蛋白逸出增加而对肺起到保护作用。